atezolizumab carboplatin/etoposide for extensive-stage small cell lung cancer: impower133 update
Published 3 years ago • 474 plays • Length 5:23Download video MP4
Download video MP3
Similar videos
-
1:50
impower133: atezolizumab, carboplatin plus etoposide for sclc
-
6:33
a win for small–cell lung cancer: impower 133
-
0:54
celebrate: carboplatin, etoposide, bevacizumab and atezolizumab in extensive-stage sclc
-
1:22
dr. horn on updated data from impower133 in small cell lung cancer
-
2:35
atezolizumab in combination with carboplatin etoposide for heavily treated small cell lung cancer
-
4:00
atezolizumab plus chemotherapy in extensive-stage small cell lung cancer
-
2:35
atezo maintenance therapy improves survival in the impower133 trial of es-sclc
-
4:59
updated survival data from a trial of atezolizumab and chemotherapy for extensive stage small cell l
-
0:26
results of celebrate: carboplatin, etoposide, bevacizumab atezolizumab es-sclc
-
8:11
first-line immunotherapy: impower133 regimen
-
5:06
impower133 in sclc
-
4:37
frontline therapy approaches for small cell lung cancer
-
0:42
beat-sc: phase iii trial of bevacizumab or placebo with atezolizumab & chemo in extensive-stage sclc
-
2:53
first-line atezolizumab plus chemotherapy improves survival in lung cancer patients
-
1:50
small cell lung cancer: interpreting data from impower133
-
7:19
impower133: is there finally a new standard of care for extensive stage sclc? (bmic-064)
-
5:15
metastatic nsclc: a look at the impower150 trial
-
3:28
advanced-stage nondriver nsclc: impower150 trial
-
0:21
small cell lung cancer affects a large number of people